Searched for
GSK INDIA INVESTMENT
Consumer firms to create nearly 5,000 jobs in 2 years as India outshines global marketsLeading consumer companies are injecting significant investment into India, creating nearly 5,000 new jobs over the next two years. This ex...
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...
Maharashtra targets Rs 30 lakh crore inflows to become a global investment hubMaharashtra targets ₹30 lakh crore in investments to become a global hub. The state is focusing on infrastructure, logistics, and clean ene...
GSK India net profit grows 13% to Rs 131 crore in Q1FY24GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter...
GSK consumer MD to head residual business post HUL deal completionThe unlisted entity has brands like Sensodyne toothpaste, Crocin analgesic and Iodex pain balm. The majority of GSK Consumer’s India portfo...
GSK Pharma in search of buyer for non-core brandsFor one of the oldest multinational drug makers in the country, the growth curve has been challenging.
GSK may put iconic Horlicks for sale to fund $13-billion Novartis dealGSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.
GSK Pharma to invest Rs 1,000 crore in Karnataka plantWe are investing Rs 1,000 crore in a new state-of-the- art pharmaceutical factory in Vemgal, Karnataka. The factory will initially supply a...
We will offer India new drugs at reasonable price: Andrew Witty, global CEO, GlaxoSmithKlineWitty talks about GSK’s India plans, the local IP laws and the debate on high pricing of drugs. Edited excerpts:
GSK Pharma trying to find out what ammunition is needed to grow: MDThe Indian arm of British drugmaker GlaxoSmithKline (GSK) is planning a major initiative to wrestle back ground it had conceded.
Novartis India gets FIPB nod to sell OTC biz to GSK CPLNovartis India today said it has received FIPB approval to sell its OTC division to GlaxoSmithKline Consumer Pvt Ltd (GSK CPL).
GSK Pharma's Bengaluru facility to be operational by 2017GSK India has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules ...
GlaxoSmithKline looks to set up Rs 1,000-crore health drink units in Andhra Pradesh“GSK is also looking at using a part of the production capacities at the proposed greenfield facility to cater to export markets.”
Weak rupee is tempting for foreign investors bringing dollars to IndiaLarge, stable Western companies have plenty of cash on their balance sheets but little option to invest in the economies of Europe and the ...
GlaxoSmithKline to spend $1 billion to raise stake in Indian pharma unitGSK said that it was looking to buy a 24% stake in the pharmaceuticals subsidiary for about $1billion or Rs 6,400 crore.
GSK to invest Rs 864 crore to set up pharma unit in IndiaGlobal pharmaceutical major GlaxoSmithKline (GSK) today announced a Rs 864 crore investment in India to set up a medicine manufacturing uni...